April 28, 2026 Erasca’s RAS-Targeting Drug Shows Promising Results in Pancreatic and Lung Cancer Trials
April 27, 2026 Regeneron Joins Major Drugmakers in Pricing Concessions Under Trump Agreements for New and Existing Medicines
April 25, 2026 Eli Lilly Acquires Kelonia Therapeutics for $3.2 Billion in Major Biotech Takeover Deal
April 25, 2026 FDA Accelerates Psychedelic Drug Review with Priority Review Vouchers for Compass, Usona and Transcend in Mental Health Push
